BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27020302)

  • 1. Hit-to-lead evaluation of a novel class of sphingosine 1-phosphate lyase inhibitors.
    Dinges J; Harris CM; Wallace GA; Argiriadi MA; Queeney KL; Perron DC; Dominguez E; Kebede T; Desino KE; Patel H; Vasudevan A
    Bioorg Med Chem Lett; 2016 May; 26(9):2297-302. PubMed ID: 27020302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors.
    Deniz U; Ozkirimli E; Ulgen KO
    J Mol Graph Model; 2016 Jan; 63():110-24. PubMed ID: 26724452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Mechanism-Based Sphingosine-1-phosphate Lyase Inhibitor.
    Pons G; Riba D; Casasampere M; Izquierdo E; Abad JL; Fabriàs G; Rodríguez Ortega PG; López-González JJ; Montejo M; Casas J; Delgado A
    J Org Chem; 2020 Jan; 85(2):419-429. PubMed ID: 31860798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of sphingosine-1-phosphate metabolism (sphingosine kinases and sphingosine-1-phosphate lyase).
    Sanllehí P; Abad JL; Casas J; Delgado A
    Chem Phys Lipids; 2016 May; 197():69-81. PubMed ID: 26200919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high-throughput scintillation proximity assay for sphingosine-1-phosphate lyase.
    Kashem MA; Wa C; Wolak JP; Grafos NS; Ryan KR; Sanville-Ross ML; Fogarty KE; Rybina IV; Shoultz A; Molinaro T; Desai SN; Rajan A; Huber JD; Nelson RM
    Assay Drug Dev Technol; 2014 Jun; 12(5):293-302. PubMed ID: 24846303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orally active 7-substituted (4-benzylphthalazin-1-yl)-2-methylpiperazin-1-yl]nicotinonitriles as active-site inhibitors of sphingosine 1-phosphate lyase for the treatment of multiple sclerosis.
    Weiler S; Braendlin N; Beerli C; Bergsdorf C; Schubart A; Srinivas H; Oberhauser B; Billich A
    J Med Chem; 2014 Jun; 57(12):5074-84. PubMed ID: 24809814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial versus human sphingosine-1-phosphate lyase (S1PL) in the design of potential S1PL inhibitors.
    Sanllehí P; Abad JL; Casas J; Bujons J; Delgado A
    Bioorg Med Chem; 2016 Sep; 24(18):4381-4389. PubMed ID: 27475537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of the sphingosine-1-phosphate signalling system.
    Zu Heringdorf DM; Ihlefeld K; Pfeilschifter J
    Handb Exp Pharmacol; 2013; (215):239-53. PubMed ID: 23579459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of sphingosine-1-phosphate lyase for the treatment of autoimmune disorders.
    Bagdanoff JT; Donoviel MS; Nouraldeen A; Tarver J; Fu Q; Carlsen M; Jessop TC; Zhang H; Hazelwood J; Nguyen H; Baugh SD; Gardyan M; Terranova KM; Barbosa J; Yan J; Bednarz M; Layek S; Courtney LF; Taylor J; Digeorge-Foushee AM; Gopinathan S; Bruce D; Smith T; Moran L; O'Neill E; Kramer J; Lai Z; Kimball SD; Liu Q; Sun W; Yu S; Swaffield J; Wilson A; Main A; Carson KG; Oravecz T; Augeri DJ
    J Med Chem; 2009 Jul; 52(13):3941-53. PubMed ID: 19489538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the inhibition of sphingosine-1-phosphate lyase by stabilized reaction intermediates and stereodefined azido phosphates.
    Sanllehí P; Abad JL; Bujons J; Casas J; Delgado A
    Eur J Med Chem; 2016 Nov; 123():905-915. PubMed ID: 27543882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assay to measure the secretion of sphingosine-1-phosphate from cells induced by S1P lyase inhibitors.
    Loetscher E; Schneider K; Beerli C; Billich A
    Biochem Biophys Res Commun; 2013 Apr; 433(3):345-8. PubMed ID: 23499842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of sphingosine-1-phosphate lyase rescues sphingosine kinase-1-knockout phenotype following murine cardiac arrest.
    Gorshkova IA; Wang H; Orbelyan GA; Goya J; Natarajan V; Beiser DG; Vanden Hoek TL; Berdyshev EV
    Life Sci; 2013 Sep; 93(9-11):359-66. PubMed ID: 23892195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of potent inhibitors of dihydroneopterin aldolase using CrystaLEAD high-throughput X-ray crystallographic screening and structure-directed lead optimization.
    Sanders WJ; Nienaber VL; Lerner CG; McCall JO; Merrick SM; Swanson SJ; Harlan JE; Stoll VS; Stamper GF; Betz SF; Condroski KR; Meadows RP; Severin JM; Walter KA; Magdalinos P; Jakob CG; Wagner R; Beutel BA
    J Med Chem; 2004 Mar; 47(7):1709-18. PubMed ID: 15027862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of a mechanism-based inhibitor of a 3-deoxy-D-arabino heptulosonate 7-phosphate synthase.
    Walker SR; Parker EJ
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2951-4. PubMed ID: 16563755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular assay for the characterization of sphingosine-1-phosphate lyase inhibitors.
    Billich A; Beerli C; Bergmann R; Bruns C; Loetscher E
    Anal Biochem; 2013 Mar; 434(2):247-53. PubMed ID: 23246729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients.
    Schwab SR; Pereira JP; Matloubian M; Xu Y; Huang Y; Cyster JG
    Science; 2005 Sep; 309(5741):1735-9. PubMed ID: 16151014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced Ca2+ storage in sphingosine-1-phosphate lyase-deficient fibroblasts.
    Claas RF; ter Braak M; Hegen B; Hardel V; Angioni C; Schmidt H; Jakobs KH; Van Veldhoven PP; zu Heringdorf DM
    Cell Signal; 2010 Mar; 22(3):476-83. PubMed ID: 19913094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell permeation of a Trypanosoma brucei aldolase inhibitor: evaluation of different enzyme-labile phosphate protecting groups.
    Azéma L; Lherbet C; Baudoin C; Blonski C
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3440-3. PubMed ID: 16632348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced Activity of Sphingosine-1-Phosphate Lyase Induces Podocyte-related Glomerular Proteinuria, Skin Irritation, and Platelet Activation.
    Schümann J; Grevot A; Ledieu D; Wolf A; Schubart A; Piaia A; Sutter E; Côté S; Beerli C; Pognan F; Billich A; Moulin P; Walker UJ
    Toxicol Pathol; 2015 Jul; 43(5):694-703. PubMed ID: 25630683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The first sphingosine 1-phosphate lyase inhibitors against multiple sclerosis: a successful drug discovery tale.
    Cosconati S; Novellino E
    J Med Chem; 2014 Jun; 57(12):5072-3. PubMed ID: 24913310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.